20 results
8-K
EX-99.1
TLRY
Tilray Brands Inc
14 May 19
Tilray, Inc. Reports First Quarter 2019 Financial Results
4:05pm
(ID); and a study with McGill University Health Centre’s Division of Infectious Diseases and Chronic Viral Illness, to examine the effectiveness
8-K
EX-99.1
TLRY
Tilray Brands Inc
13 Aug 19
Tilray, Inc. Reports Second Quarter 2019 Financial Results
4:16pm
with Intellectual Disabilities (ID); and a study with McGill University Health Centre’s Division of Infectious Diseases and Chronic Viral Illness in Quebec, Canada
DRS/A
TLRY
Tilray Brands Inc
2 May 18
Draft registration statement (amended)
12:00am
sensory neuropathies and chronic pain syndromes. As Head of the Centre for Clinical Translation, he oversees the research and development of novel … the recent success of 3 novel drugs from the laboratory to Phase II trials for chronic neuropathic pain, and one for chronic itch. He has published over 200
DRS/A
TLRY
Tilray Brands Inc
30 May 18
Draft registration statement (amended)
12:00am
mechanisms in the human sensory neuropathies and chronic pain syndromes. As Head of the Centre for Clinical Translation, he oversees the research … that has guided the recent success of 3 novel drugs from the laboratory to Phase II trials for chronic neuropathic pain, and one for chronic itch. He has
424B4
sbu9h6b ete2xq9
19 Jul 18
Prospectus supplement with pricing info
5:06pm
424B4
408b pip1ws4z
19 Jul 18
Prospectus supplement with pricing info
5:13pm
S-1
qg6hrdyndfm 8d76e8g
20 Jun 18
IPO registration
12:22pm
S-1/A
793gf1auycl77wx
9 Jul 18
IPO registration (amended)
7:07am
10-K
wmy1djuxfx20ud
25 Mar 19
Annual report
4:31pm
424B3
fr773dnndci62 762f7w
12 Nov 19
Prospectus supplement
5:20pm
S-4
6o3bxds lb
10 Oct 19
Registration of securities issued in business combination transactions
8:57pm
S-4/A
oy9r dt6zqh88
8 Nov 19
Registration of securities issued in business combination transactions (amended)
5:10pm
- Prev
- 1
- Next